miRNA-148a Enhances the Treatment Response of Patients with Rectal Cancer to Chemoradiation and Promotes Apoptosis by Directly Targeting c-Met

Patients with locally advanced rectal cancer (LARC) who achieve a pathological complete response (pCR) to neoadjuvant chemoradiotherapy (NACRT) have an excellent prognosis, but only approximately 30% of patients achieve pCR. Therefore, identifying predictors of pCR is imperative. We employed a micro...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chun-Ming, Huang, Ming-Yii, Chen, Yen-Cheng, Chen, Po-Jung, Su, Wei-Chih, Chang, Tsung-Kun, Li, Ching-Chun, Huang, Ching-Wen, Tsai, Hsiang-Lin, Wang, Jaw-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533359/
https://www.ncbi.nlm.nih.gov/pubmed/34680492
http://dx.doi.org/10.3390/biomedicines9101371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533359/
https://www.ncbi.nlm.nih.gov/pubmed/34680492
http://dx.doi.org/10.3390/biomedicines9101371

Ejemplares similares